Haemonetics Builds Whole Blood Collection Biz With Pall, Hemerus Deals
This article was originally published in The Gray Sheet
Executive Summary
Purchase of Pall’s transfusion medicine business will give Haemonetics a “meaningful” presence in the $1.2 billion global market for manual whole blood collection, adding $210 million in revenue.